Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hilpert

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
La Nouvelle Presse Medicale|December 17, 1979
[The bacteriological diagnosis of pneumonia by transtracheal puncture. Value in medical intensive care (author's transl)]J L Ricome, F Viader, E Rottman, et al.
Journal of the American College of Nutrition|July 3, 2009
Milk products, dietary patterns and blood pressure managementPenny M Kris-Etherton, Jessica A Grieger, Kirsten F Hilpert, et al.
Scandinavian Journal of Immunology|October 29, 2005
The impact of electrical charge on the viability and physiology of dendritic cellsF Hilpert, A Heiser, W Wieckhorst, et al.
Gynecologic Oncology|February 27, 2004
Docetaxel and carboplatin as first-line chemotherapy in patients with advanced gynecological tumors. A phase I/II trial of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-OVAR) Ovarian Cancer Study GroupJ Pfisterer, A du Bois, U Wagner, et al.
Nutrition Journal|January 18, 2007
An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humansAmy E Griel, Penny M Kris-Etherton, Kirsten F Hilpert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2006
Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged >or=70 years with advanced ovarian cancer--a study by the AGO OVAR GermanyF Hilpert, A du Bois, E R Greimel, et al.
The American Journal of Clinical Nutrition|February 8, 2007
Postprandial effect of n-3 polyunsaturated fatty acids on apolipoprotein B-containing lipoproteins and vascular reactivity in type 2 diabetesKirsten F Hilpert, Sheila G West, Penny M Kris-Etherton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2016
Neoadjuvant chemotherapy in ovarian cancer revisitedS Mahner, F Trillsch, D Chi, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian CancerP Harter, S Mahner, F Hilpert, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 19, 2005
Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy--a double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gynäkologische Onkologoie (AGO) Ovarian Cancer Study GroupF Hilpert, A Stähle, O Tomé, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
La Nouvelle Presse Medicale|December 17, 1979
[The bacteriological diagnosis of pneumonia by transtracheal puncture. Value in medical intensive care (author's transl)]J L Ricome, F Viader, E Rottman, et al.
Journal of the American College of Nutrition|July 3, 2009
Milk products, dietary patterns and blood pressure managementPenny M Kris-Etherton, Jessica A Grieger, Kirsten F Hilpert, et al.
Scandinavian Journal of Immunology|October 29, 2005
The impact of electrical charge on the viability and physiology of dendritic cellsF Hilpert, A Heiser, W Wieckhorst, et al.
Gynecologic Oncology|February 27, 2004
Docetaxel and carboplatin as first-line chemotherapy in patients with advanced gynecological tumors. A phase I/II trial of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-OVAR) Ovarian Cancer Study GroupJ Pfisterer, A du Bois, U Wagner, et al.
Nutrition Journal|January 18, 2007
An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humansAmy E Griel, Penny M Kris-Etherton, Kirsten F Hilpert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2006
Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged >or=70 years with advanced ovarian cancer--a study by the AGO OVAR GermanyF Hilpert, A du Bois, E R Greimel, et al.
The American Journal of Clinical Nutrition|February 8, 2007
Postprandial effect of n-3 polyunsaturated fatty acids on apolipoprotein B-containing lipoproteins and vascular reactivity in type 2 diabetesKirsten F Hilpert, Sheila G West, Penny M Kris-Etherton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2016
Neoadjuvant chemotherapy in ovarian cancer revisitedS Mahner, F Trillsch, D Chi, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian CancerP Harter, S Mahner, F Hilpert, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 19, 2005
Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy--a double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gynäkologische Onkologoie (AGO) Ovarian Cancer Study GroupF Hilpert, A Stähle, O Tomé, et al.
Pageof 4